Literature DB >> 16044030

Effect of atorvastatin on tumor necrosis factor alpha serum concentration and mRNA expression of adipose in hypercholesterolemic rabbits.

Shui-ping Zhao1, Zhi-hong Wu, Jie Wu, Shao-cai Hong, Ping Deng.   

Abstract

Tumor necrosis factor alpha (TNFalpha) is an inflammatory cytokine involved in atherogenesis. Adipose tissue is an important source of endogenous TNFalpha production. The aim of this study was to evaluate the effect of atorvastatin on TNFalpha serum concentration and mRNA expressions of subcutaneous adipose in hypercholesterolemic rabbits. Sixteen rabbits fed with a high-cholesterol diet for 8 weeks were randomly divided into 2 groups: (1) the high-cholesterol group (n=8) was maintained on a high-cholesterol diet for 6 weeks; (2) the atorvastatin group (n=8) had the same high-cholesterol diet plus atorvastatin (2.5 mg/kg/d) for 6 weeks. A control group (n=5) was fed with a normal diet for 14 weeks. Subcutaneous adipose was collected for mRNA analysis. Additionally, the direct effect of atorvastatin on TNFalpha release and mRNA expression was assayed in primary rabbit adipocytes. TNFalpha levels in serum and adipocyte culture supernatant were measured by ELISA. RT-PCR was used to evaluate TNFalpha mRNA expression in adipose and adipocytes. Serum TNFalpha concentration was significantly associated with serum total cholesterol (TC) and low-density lipoprotein-cholesterol (LDL-C) (both P<0.01). Compared with the control group, rabbits fed with a high-cholesterol diet showed higher levels of TNFalpha serum concentration and mRNA expression of adipose, both of which were significantly reduced by atorvastatin treatment (both P<0.05). TNFalpha mRNA expressions of adipose were significantly correlated with circulating TNFalpha levels among the 3 groups (r=0.51, P<0.05). Atorvastatin dose-dependently inhibited lipopolysaccharide (LPS)-induced TNFalpha secretion and mRNA expression in cultured adipocytes. In conclusion, atorvastatin can directly inhibit TNFalpha expression and secretion in adipocytes. Atorvastatin reduced TNFalpha serum concentration in hypercholesterolemic rabbits, which might be because of its cholesterol-lowering effect and direct inhibition of TNFalpha expression in adipose.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16044030     DOI: 10.1097/01.fjc.0000167017.69468.61

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  4 in total

1.  Oligofructose supplementation (10%) during pregnancy and lactation does not change the inflammatory effect of concurrent trans fatty acid ingestion on 21-day-old offspring.

Authors:  Ana Claudia Losinskas Hachul; Laís Vales Mennitti; Juliana Lopes de Oliveira; Mayara Franzoi Moreno; Marcos Hiromu Okuda; Bruno Dos Santos; Lila Missae Oyama; Eliane Beraldi Ribeiro; Claudia Maria Oller do Nascimento; Luciana Pellegrini Pisani
Journal:  Lipids Health Dis       Date:  2013-05-01       Impact factor: 3.876

2.  Hydrogenated fat intake during pregnancy and lactation caused increase in TRAF-6 and reduced AdipoR1 in white adipose tissue, but not in muscle of 21 days old offspring rats.

Authors:  Juliana L de Oliveira; Lila M Oyama; Ana Cláudia L Hachul; Carolina Biz; Eliane B Ribeiro; Claudia M Oller do Nascimento; Luciana P Pisani
Journal:  Lipids Health Dis       Date:  2011-01-25       Impact factor: 3.876

Review 3.  Role of TNF-alpha in vascular dysfunction.

Authors:  Hanrui Zhang; Yoonjung Park; Junxi Wu; Xiu ping Chen; Sewon Lee; Jiyeon Yang; Kevin C Dellsperger; Cuihua Zhang
Journal:  Clin Sci (Lond)       Date:  2009-02       Impact factor: 6.124

4.  Rosuvastatin protects against endothelial cell apoptosis in vitro and alleviates atherosclerosis in ApoE-/- mice by suppressing endoplasmic reticulum stress.

Authors:  Jianan Geng; Huali Xu; Wenwen Fu; Xiaofeng Yu; Guoliang Xu; Hongyan Cao; Guangzhu Lin; Dayun Sui
Journal:  Exp Ther Med       Date:  2020-05-08       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.